Cleared Traditional

VAMP Optima closed blood sampling system (K180275) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180275 · Edwards Lifesciences, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
266d
Days
Class 2
Risk

K180275 is an FDA 510(k) clearance for the VAMP Optima closed blood sampling system. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on October 24, 2018 after a review of 266 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Edwards Lifesciences, LLC devices

Submission Details

510(k) Number K180275 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2018
Decision Date October 24, 2018
Days to Decision 266 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
141d slower than avg
Panel avg: 125d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 67
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K180275.
Instylla Microcatheter
K191731 · Instylla, Inc. · Aug 2019
Multi-Sideport Catheter Infusion Set
K182071 · Cook Incorporated · Apr 2019
VAMP Plus Venous/Arterial Blood Management Protection System
K181684 · Edwards Lifesciences, LLC · Nov 2018
VAMP Venous/Arterial Blood Management Protection System
K173586 · Edwards Lifesciences, LLC · Apr 2018
Microcatheter and guide-wire system
K171665 · Suzhou Hengrui Disheng Medical Co., Ltd. · Jan 2018
CXI TriForce Peripheral Crossing Set
K170931 · Cook Incorporated · Nov 2017